- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 3/12 - Drugs for disorders of the metabolism for electrolyte homeostasis
Patent holdings for IPC class A61P 3/12
Total number of patents in this class: 282
10-year publication summary
|
9
|
14
|
11
|
16
|
17
|
20
|
26
|
33
|
14
|
1
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vifor (International) AG | 143 |
10 |
| Banyu Pharmaceutical Co., Ltd. | 107 |
9 |
| Daiichi Sankyo Company, Limited | 1829 |
7 |
| Renosis, Inc. | 20 |
7 |
| Ardelyx, Inc. | 109 |
6 |
| Société des Produits Nestlé S.A. | 9672 |
5 |
| MSD K.K. | 80 |
5 |
| AstraZeneca AB | 3042 |
4 |
| Ajinomoto Co., Inc. | 2337 |
4 |
| Beachbody, LLC | 642 |
4 |
| Takeda Pharmaceutical Company Limited | 2961 |
3 |
| University of Florida Research Foundation, Inc. | 3883 |
3 |
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
3 |
| Kowa Company, Ltd. | 1172 |
3 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
3 |
| Tricida, Inc. | 29 |
3 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 211 |
3 |
| Novartis AG | 11238 |
2 |
| Nestec S.A. | 2777 |
2 |
| Other owners | 193 |